By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Orchid Cellmark will provide its DNA paternity testing services to the State of Michigan under a new contract valued at around $5.2 million, the company said today.

The firm said that the contract enables it to provide its services to the Michigan Department of Human Services' Office of Child Support and the Children's Protective Services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.